Ellen Varelas, founder & CEO of LectureLinx, a global provider of innovative compliance technology and services solutions for the biopharmaceutical industry discusses the importance of compliance in the pharma industry.
Only a few years ago, compliance was the undisputed top priority in the pharmaceutical industry - regardless of cost. Companies operated under the principle that regulatory adherence was paramount, sparing no expense to ensure robust compliance programs.